Elsewhere on HealthThreads: Pancreatic cancer | Cholesterol | Prostate cancer | Heart disease | Rheumatoid arthritis | Sleep apnea | Asthma | Weight loss | Erectile dysfunction |
Diabetes Health (press release)
Both drugs are designed to lower blood glucose levels in people with type 2 diabetes, but there are concerns that they may be linked to a higher occurrence of cardiovascular problems in diabetes patients. Consequently, the committee will focus on ...
| 1 | YouTube |
| 2 | Blogcritics |
| 3 | 7thspace.com |
| 4 | ModernMedicine |
| 5 | insidermedicine.com |
| 6 | SDNN |
| 7 | Endocrine Today |
| 8 | diabetes.webmd.com |
| 9 | CMAJ |
| 10 | sev.prnewswire.com |
| 11 | ajcn.org |
| 12 | Read/WriteWeb |
| 13 | wickedlocal.com |
| 14 | WELT ONLINE |
| 15 | HealthJockey.com |
Good news for diabetics. A Patna doctor has helped develop Liraglutide, a new anti-diabetic drug, which got the approval of the Food and Drug Administration in the US for clinical use on Tuesday.
Wed, Jan 27 | from Times of India